This paper discusses alternative incentive mechanisms for encouraging pharmaceutical innovations that support global health policy priorities. Patent buyouts, in which a public fund pays a mark-up on private valuations from sealed-bid second-price auctions, would boost the efficiency of research...

Dieser Aufsatz diskutiert alternative Anreizmechanismen für pharmazeutische Innovationen zur Bewältigung globaler Gesundheitsprobleme. Patent Buyouts, bei denen ein öffentlicher Fonds einen Aufschlag auf den durch ein Auktionsverfahren ermittelten privaten Wert zahlt, würden die Effizienz...

Germany remains Europe's largest and most diversified source of new technology, but still lags in the fastest growing areas of today's high technology. After World War II, West-German technology policy sought to rebuild the institutions which had supported Germany's leadership in the high-tech...

This paper analyses the nature of knowledge spillovers from research and development (R&D) in the field of liquid crystal display technology by estimating the impact of inventors' changing organizational and collaborative affiliations on the probability of citations in US patents filed between...